<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://the483.com/intesa-monte-paschi-35-billion-bid/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-08T21:04:47.699Z</news:publication_date>
      <news:title>Intesa Outbids BPM for Monte Paschi at $35.3B</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/roche-nurix-bexobrutideg-700m/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-08T15:25:01.000Z</news:publication_date>
      <news:title>Roche Pays $700M Upfront for Nurix BTK Degrader</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/meta-ai-tool-instagram-account-hijack/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-08T14:08:16.000Z</news:publication_date>
      <news:title>Hacked: Meta AI Tool Exposed 20,225 Instagram Accounts</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/doge-stryker-fbi-breach-2026/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-08T12:30:41.000Z</news:publication_date>
      <news:title>Sued Over DOGE Breach; Tens of Thousands of Stryker Devices Wiped</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/fda-rare-disease-routes-rules-unclear/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-08T10:53:17.000Z</news:publication_date>
      <news:title>FDA Built 3 Rare Disease Routes; Key Rules Unclear</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/lilly-retatrutide-foundayo-ada-2026/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-07T21:40:50.000Z</news:publication_date>
      <news:title>Lilly Drops 28.3% Weight Loss, 73% Knee Pain Cut at ADA</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/omnilert-survivor-sues-ai-gun-detection/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-07T21:09:22.000Z</news:publication_date>
      <news:title>Survivor Sues Omnilert After $1M AI Detector Failed</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/nsa-anthropic-mythos-engineers-ban/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-07T12:04:11.000Z</news:publication_date>
      <news:title>NSA Embeds Anthropic Engineers Despite DoD Ban</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/sp500-rejects-spacex-openai-anthropic/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-07T11:23:39.000Z</news:publication_date>
      <news:title>S&amp;P Blocks SpaceX, Freezes $14B Passive Flow</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/roche-petrelintide-gi-tolerability-phase3/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-07T10:44:27.000Z</news:publication_date>
      <news:title>Roche Paid $1.65B for Petrelintide&apos;s Phase 2 GI Data</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/roche-petrelintide-9pct-sweet-spot/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-07T09:48:40.000Z</news:publication_date>
      <news:title>Roche Bets on 9% Weight Loss as Obesity Sweet Spot</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/fed-banks-private-credit-300b/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-06T22:22:24.000Z</news:publication_date>
      <news:title>Fed Orders $300B Private Credit Disclosure</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/lilly-retatrutide-cardiac-signal/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-06T21:49:13.000Z</news:publication_date>
      <news:title>Hits 30% weight loss: Lilly triple-G surfaces cardiac signal</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/pfizer-berobenatide-15pct-obesity-data/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-06T21:22:22.000Z</news:publication_date>
      <news:title>Paid $10B, Pfizer Gets Berobenatide 15.9% Obesity Data</news:title>
    </news:news>
  </url>
</urlset>